Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.
Tanner G, Barrow R, Ajaib S, Al-Jabri M, Ahmed N, Pollock S, Finetti M, Rippaus N, Bruns AF, Syed K, Poulter JA, Matthews L, Hughes T, Wilson E, Johnson C, Varn FS, Brüning-Richardson A, Hogg C, Droop A, Gusnanto A, Care MA, Cutillo L, Westhead DR, Short SC, Jenkinson MD, Brodbelt A, Chakrabarty A, Ismail A, Verhaak RGW, Stead LF. Tanner G, et al. Among authors: chakrabarty a. Genome Biol. 2024 Feb 7;25(1):45. doi: 10.1186/s13059-024-03172-3. Genome Biol. 2024. PMID: 38326875 Free PMC article.
GBMdeconvoluteR accurately infers proportions of neoplastic and immune cell populations from bulk glioblastoma transcriptomics data.
Ajaib S, Lodha D, Pollock S, Hemmings G, Finetti MA, Gusnanto A, Chakrabarty A, Ismail A, Wilson E, Varn FS, Hunter B, Filby A, Brockman AA, McDonald D, Verhaak RGW, Ihrie RA, Stead LF. Ajaib S, et al. Among authors: chakrabarty a. Neuro Oncol. 2023 Jul 6;25(7):1236-1248. doi: 10.1093/neuonc/noad021. Neuro Oncol. 2023. PMID: 36689332 Free PMC article.
Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study.
Currie S, Fatania K, Frood R, Whitehead R, Start J, Lee MT, McDonald B, Rankeillor K, Roberts P, Chakrabarty A, Mathew RK, Murray L, Short S, Scarsbrook A. Currie S, et al. Among authors: chakrabarty a. Curr Oncol. 2023 Jul 13;30(7):6682-6698. doi: 10.3390/curroncol30070490. Curr Oncol. 2023. PMID: 37504350 Free PMC article.
Opposing Interplay between Nuclear Factor Erythroid 2-Related Factor 2 and Forkhead BoxO 1/3 is Responsible for Sepantronium Bromide's Poor Efficacy and Resistance in Cancer cells: Opportunity for Combination Therapy in Triple Negative Breast Cancer.
Haider S, Chakraborty S, Chowdhury G, Chakrabarty A. Haider S, et al. Among authors: chakrabarty a. ACS Pharmacol Transl Sci. 2024 Apr 29;7(5):1237-1251. doi: 10.1021/acsptsci.3c00279. eCollection 2024 May 10. ACS Pharmacol Transl Sci. 2024. PMID: 38751638
Editorial: Resistance to endocrine therapies in cancer, volume II.
Chakrabarty A, Hiscox S, Ranganathan P. Chakrabarty A, et al. Front Endocrinol (Lausanne). 2024 Apr 23;15:1414392. doi: 10.3389/fendo.2024.1414392. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38715800 Free PMC article. No abstract available.
684 results